BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 23365127)

  • 21. Biochemical diagnosis of primary hyperparathyroidism: Analysis of the sensitivity of total and ionized calcium in combination with PTH.
    Nordenström E; Katzman P; Bergenfelz A
    Clin Biochem; 2011 Jul; 44(10-11):849-52. PubMed ID: 21515248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study.
    Rejnmark L; Amstrup AK; Mollerup CL; Heickendorff L; Mosekilde L
    J Clin Endocrinol Metab; 2013 Jan; 98(1):87-96. PubMed ID: 23150677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexisting primary hyperparathyroidism and sarcoidosis cause increased angiotensin-converting enzyme and decreased parathyroid hormone and phosphate levels.
    Lim V; Clarke BL
    J Clin Endocrinol Metab; 2013 May; 98(5):1939-45. PubMed ID: 23493435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Utility of the Cl:PO4 Ratio in Patients With Variant Versions of Primary Hyperparathyroidism.
    Wright C; King D; Small M; Gibson C; Gardner R; Stack BC
    Otolaryngol Head Neck Surg; 2021 Feb; 164(2):308-314. PubMed ID: 32746759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of measuring ionized calcium in characterizing calcium status and diagnosing primary hyperparathyroidism.
    Ong GS; Walsh JP; Stuckey BG; Brown SJ; Rossi E; Ng JL; Nguyen HH; Kent GN; Lim EM
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3138-45. PubMed ID: 22745247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary hyperparathyroidism: findings from the retrospective evaluation of cases over a 6-year period from a regional UK centre.
    Pappachan JM; Elnaggar MN; Sodi R; Jbeili K; Smith PR; Lahart IM
    Endocrine; 2018 Oct; 62(1):174-181. PubMed ID: 30019307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype.
    Lowe H; McMahon DJ; Rubin MR; Bilezikian JP; Silverberg SJ
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3001-5. PubMed ID: 17536001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism.
    Beyer TD; Solorzano CC; Prinz RA; Babu A; Nilubol N; Patel S
    Surgery; 2007 Jun; 141(6):777-83. PubMed ID: 17560254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Primary hyperparathyroidism].
    Carnevale V; Romagnoli E; Pipino M; Scillitani A; D'Erasmo E; Minisola S; Mazzuoli G
    Clin Ter; 2005; 156(5):211-26. PubMed ID: 16382970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. US-Guided Percutaneous Microwave Ablation for Primary Hyperparathyroidism with Parathyroid Nodules: Feasibility and Safety Study.
    Liu C; Wu B; Huang P; Ding Q; Xiao L; Zhang M; Zhou J
    J Vasc Interv Radiol; 2016 Jun; 27(6):867-75. PubMed ID: 27106734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum calcium (S-Ca), the forgotten test: preliminary results of an appropriateness strategy to detect primary hyperparathyroidism (pHPT).
    Salinas M; López-Garrigós M; Pomares F; Lugo J; Asencio A; López-Penabad L; Dominguez JR; Leiva-Salinas C
    Bone; 2013 Sep; 56(1):73-6. PubMed ID: 23707628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased plasma concentrations of N-terminal pro-B-type natriuretic peptide in patients with mild primary hyperparathyroidism.
    Almqvist EG; Becker C; Bondeson AG; Bondeson L; Svensson J; Svensson SE
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):760-6. PubMed ID: 17121527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is intraoperative parathyroid hormone monitoring necessary with ipsilateral parathyroid gland visualization during anticipated unilateral exploration for primary hyperparathyroidism: a two-institution analysis of more than 2,000 patients.
    Rajaei MH; Oltmann SC; Adkisson CD; Elfenbein DM; Chen H; Carty SE; McCoy KL
    Surgery; 2014 Oct; 156(4):760-6. PubMed ID: 25239313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-super-selective venous sampling for persistent hyperparathyroidism using a systemic hypocalcemic challenge.
    Morris LF; Loh C; Ro K; Wiseman JE; Gomes AS; Asandra A; Wariri S; Yeh MW
    J Vasc Interv Radiol; 2012 Sep; 23(9):1191-9. PubMed ID: 22832137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anaemia and marrow fibrosis in patients with primary hyperparathyroidism before and after curative parathyroidectomy.
    Bhadada SK; Bhansali A; Ahluwalia J; Chanukya GV; Behera A; Dutta P
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):527-32. PubMed ID: 18727711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type I membrane klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism.
    Björklund P; Krajisnik T; Akerström G; Westin G; Larsson TE
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4152-7. PubMed ID: 18682507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of final intraoperative parathyroid hormone level and outcome following parathyroidectomy.
    Heller KS; Blumberg SN
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1103-7. PubMed ID: 19917922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different PTH response to oral peptone load and oral calcium load in patients with normocalcemic primary hyperparathyroidism, primary hyperparathyroidism, and healthy subjects.
    Invernizzi M; Carda S; Righini V; Baricich A; Cisari C; Bevilacqua M
    Eur J Endocrinol; 2012 Oct; 167(4):491-7. PubMed ID: 22872468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and treatment strategies on primary hyperparathyroidism].
    Li X; Zhang S; Sun R; Yang J; Ren Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 May; 27(9):449-50, 454. PubMed ID: 23898606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism.
    Boudou P; Ibrahim F; Cormier C; Sarfati E; Souberbielle JC
    J Endocrinol Invest; 2006 Jun; 29(6):511-5. PubMed ID: 16840828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.